Journal
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
Volume 37, Issue 5, Pages 453-469Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10799893.2017.1328442
Keywords
Comparative molecular field analysis; comparative molecular similarity indices analysis; partial least squares analysis; Janus kinase; extra precision; molecular dynamics
Categories
Funding
- Science and Engineering Research Board [SB/EMEQ-004/2013]
- Council for Scientific and Industrial Research [01/(2436)/10/EMR-II]
- University Grants Commission New Delhi, India [42-233/2013(SR)]
Ask authors/readers for more resources
Janus kinase 1 (JAK 1) belongs to the JAK family of intracellular nonreceptor tyrosine kinase. JAK-signal transducer and activator of transcription (JAK-STAT) pathway mediate signaling by cytokines, which control survival, proliferation and differentiation of a variety of cells. Three-dimensional quantitative structure activity relationship (3D-QSAR), molecular docking and molecular dynamics (MD) methods was carried out on a dataset of Janus kinase 1(JAK 1) inhibitors. Ligands were constructed and docked into the active site of protein using GLIDE 5.6. Best docked poses were selected after analysis for further 3D-QSAR analysis using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methodology. Employing 60 molecules in the training set, 3D-QSAR models were generate that showed good statistical reliability, which is clearly observed in terms of r(ncv)(2) and q(loo)(2) values. The predictive ability of these models was determined using a test set of 25 molecules that gave acceptable predictive correlation (r(Pred)(2)) values. The key amino acid residues were identified by means of molecular docking, and the stability and rationality of the derived molecular conformations were also validated by MD simulation. The good consonance between the docking results and CoMFA/CoMSIA contour maps provides helpful clues about the reasonable modification of molecules in order to design more efficient JAK 1 inhibitors. The developed models are expected to provide some directives for further synthesis of highly effective JAK 1 inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available